Author:
Hartmann F.,Freiberg E.,Ruge W.
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Genetics(clinical),Drug Discovery,Molecular Medicine
Reference24 articles.
1. Kähler, H., u.L. Heilmeyer: Klinik und Pathophysiologie des Karzinoids und Karzinoidsyndroms unter besonderer Berücksichtigung der Pharmakologie des 5-Hydroxytryptamins. InL. Heilmeyer, R. Schoen, B. de Rudder, Ergebn. inn. Med. Kinderheilk., N.F.,16 (1961).
2. Davison, A. N., andM. Sandler: Inhibition of 5-hydroxytryptophan decarboxylase by phenylalnine metabolites. Nature (Lond.)181, 186 (1958).
3. Dalgliesh, C. E.: Isolation and examination of urinary metabolites containing an aromatic system. J. clin. Path.8, 73 (1955).
4. Dalgliesh, C. E.: Two-dimensional paper chromatography of urinary indoles and related substances. Biochem. J.64, 481 (1956).
5. Dalgliesh, C. E.: The 5-hydroxyindoles. In: Advances in clin. chem.H. Sobotka, C. P. Stewart, edit., vol. 10. New York and London: Academic Press 1955.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献